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Abstract
The fruitfly Drosophila melanogaster is well established as a model system in the study of human neurodegenerative
diseases. Utilizing RNAi, we have carried out a high-throughput screen for modifiers of aggregate formation in Drosophila
larval CNS-derived cells expressing mutant human Huntingtin exon 1 fused to EGFP with an expanded polyglutamine repeat
(62Q). 7200 genes, encompassing around 50% of the Drosophila genome, were screened, resulting in the identification of
404 candidates that either suppress or enhance aggregation. These candidates were subjected to secondary screening in
normal length (18Q)-expressing cells and pruned to remove dsRNAs with greater than 10 off-target effects (OTEs). De novo
RNAi probes were designed and synthesized for the remaining 68 candidates. Following a tertiary round of screening, 21
high confidence candidates were analyzed in vivo for their ability to modify mutant Huntingtin-induced eye degeneration
and brain aggregation. We have established useful models for the study of human HD using the fly, and through our RNAi
screen, we have identified new modifiers of mutant human Huntingtin aggregation and aggregate formation in the brain.
Newly identified modifiers including genes related to nuclear transport, nucleotide processes, and signaling, may be
involved in polyglutamine aggregate formation and Huntington disease cascades.
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Introduction
Huntington Disease (HD) is a late-onset, autosomal dominant
neurodegenerative disorder characterized at the genetic level by
expansion of a CAG repeat in the huntingtin (htt) gene. HD,
together with 8 other diseases including the Spinocerebellar
Ataxias (SCAs), DRPLA and SBMA, is classified as a CAG repeat
disease. Expansion of the CAG repeat in exon 1 of the htt gene to
greater than 35 repeats results in a disease-causing expanded
polyglutamine tract in the Htt protein. Mutant Htt is aggregation-
prone, and acquires a toxic gain-of-function (GOF) by interfering
with, or disrupting, normal cellular pathways such as the
ubiquitin-proteasome system (UPS), transcriptional regulation,
and signaling pathways [1]. In HD, medium spiny neurons of the
striatum are selectively affected, leading to the clinical features of
the disease including chorea, cognitive abnormalities and
psychiatric disturbance.
Researchers have long been aware of the benefits of using
Drosophila melanogaster to study human disease, particular diseases of
the nervous system. The fly is particularly amenable to
sophisticated genetic approaches and the ability to temporally
and spatially control the expression of transgenes is a powerful
advantage of this system. CAG repeat diseases, caused by a toxic
GOF, can be modeled in the fly by expression of the mutant
protein. Drosophila models for SCA 1, SCA 3, MJD, SMBA and
DRPLA have been successfully established and mimic various
aspects of this group of diseases such as the presence of mutant
protein aggregates, progressive neurodegeneration and behaviour-
al abnormalities [2,3,4,5].
In recent years, RNAi has become a powerful approach to study
gene loss-of-function (LOF). The relative ease with which genes
can be ablated in insect cells has lead researchers to carry out
large-scale and even genome-wide analyses to study the effects of
gene LOF on various cellular pathways [6,7]. The problem of off-
target-effects (OTEs) has raised some concern over previously
published results, and highlighted the importance of thorough
validation of candidates identified in large scale RNAi screens
through a variety of techniques [8,9].
We have combined a high throughput RNAi screen with in vivo
candidate validation to identify potential new regulators of mutant
human Htt aggregation. Although there are some controversies
about polyglutamine aggregate and cellular toxicity, aggregate
formation is a main pathological feature and detecting modulators
of aggregation may help our understanding of the pathological
process of Huntington disease. By establishing an in vitro model of
HD in Drosophila cells stably expressing htt exon 1 fused to EGFP
with an expanded polyQ tract (62Q), we screened 7200 dsRNA
molecules for their effects on mutant htt aggregation. We
identified 404 candidate dsRNAs that could either suppress or
enhance aggregation. We carried out secondary and tertiary
screening in our cell culture model to select the strongest
candidates and investigated these candidates further using in vivo
models of HD established for this purpose. Transgenic flies were
established that express htt exon1 fused to EGFP with either
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7275normal length (18Q) or expanded (62Q or 152Q) and either with
or without an NLS for nuclear targeting.
To our knowledge, this is the first Drosophila RNAi screen for
modifiers of a mutant human aggregating protein. We have
identified and thoroughly validated 21 candidate genes in our
study using in vivo fly models of HD. These candidate genes may
shed light on the underlying pathways important in the
development and pathogenesis of human HD.
Results
Primary high-throughput RNAi screening in cultured cells
To utilise high throughput RNAi screening in Drosophila cells to
identify genes that modify aggregation of polyglutamine-expanded
human huntingtin exon 1, we established an in vitro cell culture
model of human HD as described in Materials and Methods.
BG2-c2 cells [24] were chosen to enrich for candidates expressed
in neuronal cells. Nhtt(18Q)EGFP predominantly localized to the
cytosol with perinuclear accumulation and some punctate staining
perhaps indicative of nuclear and other intracellular membrane
association [10]. In contrast, Nhtt(62Q)EGFP with a pathogenic
number of glutamine residues formed cytoplasmic inclusions
within 16 hours of induction (Figure 1A).
For large-scale screening, we needed a rapid method to detect
the number of intracellular inclusions in the cell. The Cellomics
ArrayScanH is able to detect intracellular objects based on a user-
defined protocol. We devised a protocol to count the number of
EGFP-positive inclusions and also estimate inclusion size based on
the number of pixels of EGFP fluorescence for the objects detected
in stable BG2- Nhtt(62Q)EGFP cells. We tested the efficacy of
RNAi by treating BG2- Nhtt(18Q)EGFP cells with dsRNA against
EGFP. Efficient knockdown was achieved within 48 hours of
treatment using the bathing method (Figure S1A) and led to the
reduction of both EGFP-positive cells (Figure S1B) and EGFP-
positive inclusions (Figure S1C) as detected by ArrayScanH in
BG2-Nhtt(62Q)EGFP cells. Given our aim to identify candidate
molecules that could modify aggregation of a human disease
protein using a Drosophila cell culture model, we chose to screen the
Open Biosystems RNAi library because it is enriched for Drosophila
orthologues of mammalian proteins. We prepared dsRNA using
dsDNA templates provided in the library, as described in
Materials and Methods. Prior to beginning large-scale screening,
we ran a test plate through the treatment protocol to ensure that
the dsRNAs made were able to ablate gene expression. We
selected the library plate containing dsRNA against diap1, a gene
essential for the survival of Drosophila cells. Cells treated with diap1
dsRNA had significantly reduced cell viability (22% compared
with plate average) demonstrating that the method of treatment
and quality of dsRNAs was sufficient for screening (Figure S1D).
We therefore proceeded to screen the 7200 library dsRNAs (75 96-
well plates) in duplicate to identify dsRNAs that could either
enhance or suppress Nhtt(62Q)EGFP aggregation using the
Cellomics ArrayScanH. Candidates were selected based on their
calculated z score, indicating the extent of difference from the
plate mean in terms of standard deviations. An outline of our
screening approach is shown in Figure S1E.
Of the 7200 dsRNAs screened, we identified 404 candidates
that modified Nhtt(62Q)EGFP aggregation. Of these, 32 had
positive z scores ($2) indicating that the dsRNA could enhance
aggregation, and 372 candidates had negative z scores (#22)
resulting from suppression of aggregation by dsRNA treatment
(Figure 1B). Figure 1C shows the screen reproducibility over the
two individual treatment assays. Using FlyBase and FLIGHT
database batch download options, we automatically retrieved
Gene Ontology (GO) terms for each candidate and then manually
assigned functional groups based on this information. Interesting-
ly, functional groups represented by aggregate-suppressing
Figure 1. High-throughput RNAi screening in a Drosophila cell
culture model of HD. Drosophila BG2 cells stably expressing
Nhtt(18Q)EGFP(top panel) or Nhtt(62Q)EGFP. Induction withCuSO4 shows
predominantly cytoplasmic localization of Nhtt(18Q)EGFP with some
perinuclear accumulation and cytoplasmic puncta. Large, cytoplasmic
inclusions form upon expression of Nhtt(62Q)EGFP. Scale bar represents
18.75 mm( A). BG2-Nhtt(62Q)EGFP cells were treated with 7200 dsRNAs
and the mean number of inclusions/cell detected by ArrayScanH across
duplicate treatments were used to calculate the z score for each dsRNA.
The mean z score for each dsRNA is represented as a scatter plot (B).
Screen reproducibility across two independent treatments is shown (C).
doi:10.1371/journal.pone.0007275.g001
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enhancing dsRNAs (Figure 2). Our full candidate list with z scores,
viability scores and functional group categorization is presented as
an excel spreadsheet in Data S1.
Multiple predicted OTEs contribute to false positives and
data skew
Our data showed a strong skew towards candidates with
negative z scores; those dsRNAs that suppressed mutant Htt
aggregation. Using the FLIGHT database to retrieve the RNAi
probe sequence for each of our candidates, and then determining
the number of predicted OTEs using the DRSC website tool, we
were able to correlate our results with the number of OTEs in our
candidate list. Transcription factors (TFs) are notoriously sensitive
to potential OTEs due the prevalence of trinucleotide repeats in
many TF-encoding genes. Not surprisingly, therefore, we found
that the category representing ‘Specific Transcription’ was the
most severely reduced when candidates with more than 10
predicted OTEs were excluded (Figure S2). Exclusion of such
candidates impacted the aggregate-suppressing candidates most
notably, accounting for, in part, the skew in our data. Of note, we
found a significant negative correlation between cell viability and
the number of predicted OTEs (Figure S3A) adding further
caution to growing data concerning the problems of gene off-
targeting in Drosophila RNAi experiments. Furthermore, dsRNAs
with many predicted OTEs are overrepresented amongst our list
of candidates, with 44% having more than 10 potential OTEs
compared with 5.7% of the entire RNAi library (Figure S3B). It is
therefore clear that OTEs contribute to false positive candidates in
this library.
Secondary screening in 18Q cells
To eliminate aggregate-suppressing dsRNAs that reduced the
number of aggregates simply by reducing transgene expression in
our stable cell line, we treated BG2-Nhtt(18Q)EGFP with dsRNAs
identified as candidates in our primary screen. Excepting the
Figure 2. Functional categorization of primary screen candidates. 404 candidates identified through primary RNAi screening were placed
into functional groups based on Gene Ontology terms for Biological Process and Molecular Function retrieved from FlyBase and FLIGHT databases.
Aggregation-enhancing dsRNAs (left charts) and aggregation-suppressing dsRNAs (right charts) are represented by largely distinct functional groups
(top charts). Functional group representations following secondary screening in Nhtt(18Q)EGFP cells, where candidates were pruned to eliminate
dsRNAs which non-specifically reduced the expression of Nhtt(18Q)EGFP and those with greater than 10 predicted 19 nt OTEs and shown in the
lower charts. Numbers at the centre of each pie chart indicate the total number of candidates and peripheral numbers indicate the number of
candidates represented by that category. OTE pruning and elimination of candidates following secondary screening largely reduced the number of
aggregate-suppressing dsRNAs, particularly those represented by the specific transcription functional group.
doi:10.1371/journal.pone.0007275.g002
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primary screening and ArrayScanH data for the percentage of
EGFP-positive cells and EGFP intensity was obtained. We decided
to take a stringent approach to candidate pruning and eliminated
candidates that did not reduce the percentage of EGFP-positive
cells by more than 10% compared to the average for a LacZ
control. Treatment with a LacZ dsRNA alone reduced the %
EGFP-positivity compared to untreated cells. At the time of
secondary screening, the problem of off-target effects was not fully
known. Since this issue came to light, we discovered that the LacZ
control dsRNA used in our secondary screen had one predicted
off-target. This potentially resulted in the retention of more
candidates following secondary screening because the LacZ
control showed some decrease in EGFP positivity. We therefore
designed a new LacZ control dsRNA (NewLacZ) for all
subsequent tertiary screening and biochemical analyses in vitro.
We also confirmed that the potential off-target gene (pcx) had
some effect on EGFP expression and aggregation (data not shown).
We could not distinguish between candidate dsRNAs that reduced
the Nhtt(18Q)EGFP fluorescence by enhancing proteolytic
pathways or by general transcriptional reduction. Thus, some
genuine candidates may have been excluded following secondary
screening. Functional groups of enhancer and suppressor dsRNA
following OTE pruning and secondary screening are shown in
Figure 2 (lower charts).
Tertiary screening using de novo designed RNAi probes
To further confirm the effect of candidate dsRNAs that passed
through previous rounds of screening, we independently designed
and synthesized dsRNA probes, spanning a different region of the
gene from the library dsRNA. De novo probes were designed using
the E-RNAi software [11]. Primer pairs were selected for their
specificity, and for their ability to target all isoforms of a given
gene. The size and integrity of PCR amplicons and synthesized
dsRNAs were checked by non-denaturing and denaturing agarose
gel electrophoresis respectively (Figure S4A). Details of primer
design and synthesis of dsRNA probes can be found in Supporting
Methods. In the primary screen, we used a relatively high
concentration of dsRNA (100 nM). We treated cells with two
concentrations, one estimated to be 108 nM, similar to primary
screen treatment concentration, and the other lower concentration
43 nM, slightly above the optimal concentration reported [7]. We
initially carried out RT-PCR using Htt primers to confirm that
dsRNAs do not affect Htt expression and did not see a noticeable
difference in expression level of the Htt transgene (data not
shown).
Tertiary screen candidates were also tested for their effects on
the expression level of BG2-Nhtt(18Q)EGFP cells. Based on
tertiary screening results, we selected 21 candidates that modified
mutant Htt aggregation in the direction consistent with primary
screening results and eliminated candidates that drastically altered
EGFP fluorescence. These 21 candidates were placed into 3
groups, based on the percentage difference in expression level of
normal length htt (18Q). Group 1 candidates differed in 18Q
expression by no more than 10%, group 2 by no more than 20%
and group 3 by no more than 30% (Table 1). ArrayScanH results
for candidate groups 1–3 are shown in Figure 3A and the level of
target gene knockdown by dsRNA is demonstrated by RTPCR in
Figure S4B. Confocal images of BG2-Nhtt(62Q)EGFP and
Nhtt(18Q)EGFP cells treated with group 1 candidate modifiers
are shown in Figure 3C. Figure S5A shows confocal images for the
12 aggregate-suppressing dsRNAs and Figure S5B shows the 9
aggregate-enhancing dsRNAs.
Biochemical validation of aggregation
To further validate the effect of each candidate on mutant Htt
aggregation, we treated BG2-Nhtt(62Q)EGFP cells with candidate
groups 1–3 dsRNAs and prepared whole cell lysates for Western
blotting. Although the immunoreactive signal of SDS-insoluble
Nhtt(62Q)EGFP residing the gel top is only a qualitative way to
assess the amount of mutant Htt aggregation, we consistently
observed differences in the level of gel top material by treatment
with our candidate dsRNAs (Figure 3B), adding further confidence
to results obtained by ArrayScanH.
Validation of RNAi screen candidates in the Drosophila
compound eye
In order to follow up interesting candidates in vivo,w e
established transgenic flies for expression of EGFP-tagged Nhtt
with either a normal (18Q) or expanded (152Q) polyglutamine
tract and either lacking or containing a nuclear localization signal
(NLS). We established UAS-NhttEGFP lines for driving transgene
expression in various cell types. We have found that heterozygous
expression of non-nuclear mutant Htt using the GMR-Gal4 driver
does not produce a strong external eye phenotype, compared to a
moderate loss of pigmentation phenotype caused by NLS-
containing mutant Htt (data not shown). For genetic modification
of Htt-induced cellular toxicity, we established a Drosophila line that
expresses mutant Htt in both the cytoplasm and nucleus of all
neurons and other cell types of the developing and adult
compound eye using the GMR-Gal4 driver. We confirmed the
presence of Nhtt(48Q)EGFP
NLS inclusions in the nucleus and
Nhtt(152Q)EGFP inclusions in the cytosol by confocal microscopic
imaging of 3
rd instar larval eye discs (Figure S6). These flies
produce a degenerative eye phenotype characterized by loss of
pigment cells and an increased occurrence of dark necrotic spots
on the external eye while flies expressing Nhtt(18Q)EGFP/
Nhtt(18Q)EGFP
NLS have a normal eye phenotype at the same
age (Figure 4A). There was no noticeable alteration of this
phenotype in flies carrying an extra UAS insertion (Figure 4B).
We took advantage of the availability of UAS-dsRNA lines
provided by the VDRC stock centre in Vienna, Austria [12] and
the NIG stock centre in Mishima, Japan. Where RNAi stocks were
not available, overexpression lines were obtained from the
Bloomington stock centre. Our flies, expressing mutant Htt in
the eye, were crossed to candidate RNAi or overexpression (OE)
stocks. We observed a significant degree of variation amongst the 3
week old progeny in some crosses (data not shown for all
candidates). Therefore, we selected the strongest, most consistent
candidates that enhanced or suppressed the eye phenotype caused
by mutant Htt to test again using the same model.
The novel gene, CG1109, most strongly suppressed
Nhtt(62Q)EGFP aggregation in cultured cells when ablated by
RNAi (Figure 3). CG1109 RNAi also strongly suppressed mutant
Htt-induced toxicity in vivo in the fly eye (Figure 4C). The UAS-
CG1109 RNAi transgene is carried on the X chromosome. Thus,
using males carrying this transgene crossed to our HD females,
progeny females carried the UAS-CG1109 RNAi transgene and
demonstrated a strong suppression of the mutant Htt-induced
phenotype compared to males that lacked the UAS-CG1109
RNAi transgene (Figure 4C). We found that dsRNAs targeting
CG5537 and CG4738, the Drosophila homologue of Nup160, could
suppress, to some extent, the loss of pigmentation phenotype in
these flies (Figure 4D and 4E respectively). Furthermore, we
observed a clear decrease in the number of necrotic fly eyes in
these progeny (data not shown). Although UAS-Hiw RNAi
showed some enhancement of the eye phenotype in the
preliminary round of screening, we were unable to obtain
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PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e7275Figure 3. ArrayScanH data, Western Blotting and confocal analysis of selected candidates. Following secondary screening and OTE
pruning, de novo dsRNA probes were designed for the remaining candidates. BG2-Nhtt(62Q)EGFP cells and BG2-Nhtt(18Q)EGFP cells were treated in
duplicate with these de novo probes. Candidate groups 1 to 3 ArrayScanH data for the mean number of inclusions/cell and the mean inclusion load/
cell (# inclusions X mean inclusion size/# cells) as a percentage of the NewLacZ control dsRNA are shown. dsRNA against dhdJ1 was used as a
control. Error bars represent +/2 SD. (A). BG2-Nhtt(62Q)EGFP cells treated with de novo dsRNAs were analyzed biochemically by Western blotting
with a-Htt antibody (EM48). SDS-insoluble (gel-top) material is shown in the top panel (B). BG2-Nhtt(62Q)EGFP cells and BG2-Nhtt(18Q)EGFP treated
with de novo dsRNAs were analyzed by confocal microscopy. Confocal images for group 1 candidates are shown (C). For imaging aggregation-
suppressing dsRNAs in BG2-Nhtt(62Q)EGFP cells, EGFP gain was increased in order to show the increase in cells with diffuse expression compared to
the NewLacZ control. EGFP gain was reduced for imaging aggregate-enhancing dsRNAs due to the intensity of fluorescence in highly-aggregating
cells.
doi:10.1371/journal.pone.0007275.g003
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PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e7275consistent results with this candidate. However, a slight rough eye
with disruption to eye bristles was observed in a mutant Htt-
independent manner (Figure 4F). Overexpression of Rheb
enhanced the phenotype of mutant Htt flies, with a severe rough
eye phenotype and enhancement of pigment cell loss (Figure 4G
right panels). However, overexpression of Rheb in flies expressing
our NhttEGFP transgene with a normal length polyQ repeat
(Figure 4G left panels) or expression of UAS-Rheb alone (data not
shown) also resulted in a rough eye phenotype with bristle
disorganization. As a control, we used the overexpression of the
Drosophila homologue of heat shock protein 40, dhdJ1, to suppress
the mutant Htt eye phenotype (Figure 4H).
Validation of RNAi screen candidates in aged adult fly
brain
We further confirmed the validity of CG5537 and CG4738
RNAi by quantification of mutant Nhtt(98Q)EGFP brain
aggregates. 4 week old male brains, from Elav-Gal4, UAS-
Nhtt(98Q)EGFP recombinant lines were dissected and stained
with anti-elav antibody and Hoechst 33345. We quantified the
number and size of brain aggregates from stacked images of 5 mm
confocal sections, using ImageJ software. We observed a significant
decrease in the average number of visible inclusions in each brain
by expression of UAS-CG4738 RNAi and UAS-CG5537 RNAi
(Figure 5B and 5C). Although Rheb overexpression did not
significantly increase the number of brain inclusions or the
inclusion load, the average aggregate size was increased
(Figure 5C).
In summary, by using various in vivo models of HD we have
validated the effect of several candidate genes identified through a
large-scale RNAi screen for modifiers of mutant Htt aggregation.
Discussion
To make use of the amenability of cultured Drosophila cells to
gene knockdown by RNAi, we aimed to screen a library of dsRNA
molecules covering around half of the fly genome and enriched for
fly genes with mammalian homologues, for modifiers of
Htt(62Q)EGFP aggregation. We carried out several rounds of
screening to identify such modifier dsRNAs and carefully
confirmed our screen results by addressing issues such as non-
specific transcript reduction and potential gene off-targeting.
Following our stringent screening method, our final 3 groups of
candidates were assessed biochemically by Western Blot analysis
and visually by confocal microscopy.
Our candidates fell into several functional groups, the most
notable being transport molecules, including those involved in
nuclear transport, and nucleotide processing including RNA
metabolism. Nuclear transport has been reported to be important
in mutant Htt pathogenesis, with Htt itself reportedly shuttling
between the nucleus and the cytoplasm [10,13]. RNA metabolic
processes are receiving increasing attention in the neurodegener-
ative field and RNA binding proteins have been identified as
polyglutamine aggregate-interacting proteins and contributing to
polyglutamine disease pathogenesis [14,15]. Although we identi-
fied many genes through RNAi screening with predicted
involvement in the Ubiquitin Proteasome System (UPS), most
were aggregation-suppressing. This may be due to the essential
role of many of these genes, most of which were eliminated by
OTE pruning and secondary screening for reduction of
Nhtt(18Q)EGFP, although we cannot exclude the possibility that
some eliminated dsRNAs might reduce Nhtt(18Q)EGFP expres-
sion by enhancing cellular proteolytic activities. Loss of the
ubiquitin ligase highwire consistently resulted in an increase in
Figure 4. Selected screen candidates modify mutant Htt-
induced toxicity in the fly eye. GMR-Gal4-driven expression of
UAS-Nhtt(152Q)EGFP, UAS-Nhtt(48Q)
NLS in the compound eye results in
a progressive loss of pigmentation compared to expression of UAS-
Nhtt(18Q)EGFP, UAS-Nhtt(18Q)
NLS (A). Carrying an extra UAS transgene
does not noticeably alter this phenotype (B). Female flies carrying a
UAS-CG1109 RNAi transgene on the X chromosome show a clear
suppression of the mutant Htt-induced toxicity phenotype, whereas no
clear modification is seen in male flies lacking the UAS-CG1109 RNAi
transgene (C). Expression of UAS-CG5537 RNAi on the X chromsome
(D), and an autosomal UAS-CG4738 RNAi transgene (E) also suppress
the mutant Htt-induced degenerative phenotype, with a rescue of
pigmentation in these flies. Note: both males and females carry a copy
of the for the UAS-CG5537 RNAi transgene as explained in Materials and
Methods. Flies carrying a UAS-hiw RNAi transgene showed a slight
rough eye phenotype that was also observed when coexpressed with
normal Htt (F). Overexpression of Rheb resulted in a drastic
enhancement of the Htt phenotype with an increase in black necrotic
patches, further loss of pigmentation and a rough eye with bristle
disorganization (G). Overexpression of Rheb in flies expressing normal
Htt also resulted in a rough eye phenotype with a mild loss of
pigmentation. The chaperone molecule, dhdJ1 clearly suppressed Htt-
induced loss of pigmentation when overexpressed (H). All flies were
aged between 21 and 22 days.
doi:10.1371/journal.pone.0007275.g004
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PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7275mutant Htt inclusion number and size in our cell culture model of
HD and appeared to enhance the eye degeneration phenotype of
mutant Htt, although the high degree of phenotypic variability
with the UAS-hiw RNAi lines used made it difficult to reach a sure
conclusion on the role of this gene in HD pathogenesis.
Furthermore, no significant difference was found in the number
or size of inclusions in aged adult brains expressing UAS-hiw
RNAi (Figure 5).
Our screen was biased towards detecting suppressors due to the
high aggregation propensity of our cell line. Investigation of
aggregation-enhancing dsRNAs with z scores slightly below our
+2SD cut-off (z scores between 1.5 and 2) revealed several UPS
dsRNAs of the ubiquitin-ligase class. This is consistent with the
role played by the UPS system in targeting mutant Htt for
degradation. This group of enhancers can be viewed as an excel
spreadsheet in Data S1.
To further validate our high-confidence candidates, we estab-
lished in vivo models of HD to investigate whether or not these genes
are likely to be involved in mutant Htt toxicity and/or modification
of mutant Htt aggregation in vivo. The Drosophila compound eye has
longbeenutilized to assesspotential genetic interactions particularly
in the fields of apoptosis and degeneration in part because the eye is
sensitive to cell loss and produces a visible phenotype when the
highly organized ommatidial structure is disrupted. Furthermore,
the eye is not essential for viability, allowing genetic interactions to
be investigated in the adult, even with highly toxic gene products.
We were able to validate the role of several of our gene candidates
using the fly eye as a model system. Expression of UAS-CG4738
RNAi and UAS-CG5537 RNAi transgenes resulted in a noticeable
and consistent suppression of the loss of pigmentation phenotype
caused by heterozygous expression of Nhtt(48Q)EGFP
NLS and
Nhtt(152Q)EGFP (Figure 4). We also observed a strong suppression
of this phenotype with UAS-CG1109 RNAi and a strong
enhancement of the phenotype by overexpression of Rheb,
consistent with the role of autophagy in Htt aggregation [16,17].
Limiting our in vivo validation of candidates to the eye raised
several problems. Although the eye is valuable as a toxicity model,
the relationship between polyglutamine aggregation and toxicity is
not clear in the eye. Overexpression of the heat shock protein 40
homologue, dhdJ1, demonstrates a drastic suppression of ataxin 1-
induced toxicity [18] and in our hands, this same transgene
resulted in suppression of mutant Htt-induced toxicity. However,
suppression of polyglutamine toxicity was independent of a visible
change in ataxin-1 aggregation [18]. We therefore set out to assess
the role of selected candidates in aggregation of mutant Htt in
aged adult fly brain. Our aggregation model, expressing one copy
of a UAS-Nhtt(93Q)EGFP transgene using the pan-neuronal
driver, elav-Gal4, formed visible inclusions in the brain and optic
lobes (Figure 5A). Although all progeny differed in age by no more
than 24 hours, there was a high degree of variation in the number
and size of visible inclusions. Nevertheless, we found a significant
reduction in the number of inclusions and overall inclusion load by
expression of UAS-CG4738 RNAi and UAS-CG5537 RNAi. We
could not obtain a clear brain aggregation result for CG1109 due
to poor brain quality for all progeny from this cross. CG1109 is a
novel gene, recently identified in a primary neuronal RNAi screen
Figure 5. CG5537 and CG4738 RNAi transgenese suppress
Htt(93Q)EGFP aggregation in aged Drosophila brain. 4-week old
(28–29 days) fly brains were dissected from male flies and stained with
a-elav antibody (magenta), imaged by confocal microscopy and 5 mmz
stacks projected into one image (A). Compared to elav-Gal4, UAS-
Nhtt(93Q)EGFP/wt flies, flies carrying a UAS-CG5537 RNAi or UAS-
CG4738 RNAi transgene show a significant reduction in the mean
number of inclusions (B) and the mean overall inclusion load (#
inclusions X mean inclusion size) (D) with no significant reduction in
inclusion size observed (C). UAS-hiw RNAi and UAS-dhdJ1 had no
significant effect on the number, size or load of inclusions (B–D
respectively). UAS-Rheb significantly increased the mean inclusion size
(C), however there was an insignificant reduction in inclusion number
(A) with no significant change in overall inclusion load (D). Error bars
represent +/2 SEM. The total number of brains imaged and scored
from 1 to 3 experiments are indicated in the data box. ** p#0.0008,
*p #0.008, Student’s t test.
doi:10.1371/journal.pone.0007275.g005
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PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e7275for genes required for neurogenesis [19]. CG1109 may therefore
be essential for neuron function and pan-neuronal expression of an
RNAi construct may be toxic.
We were unable to detect a significant reduction in mutant Htt
inclusions in the brain by overexpression of dhdJ1. It is possible
that dhdJ1 requires some cofactor for its function as a heat shock
protein that may be lacking in elav-positive neurons in the fly
brain. However, given that so many studies use the eye for
validation of polyglutamine modifiers, it should be noted that
perhaps not all such modifiers will prove valid in models for
mutant Htt aggregation. Our strongest candidates, CG4738 and
CG5537 were validated by two independent RNAi stocks in the
eye model (Figure 4 and data not shown).
Although some corresponding results were observed between
suppressor activity in the cellular system and reducing toxicity in eye,
the discrepancy is not unexpected. Even in our cellular system, based
on the inclusion formation and cellviability, a distinct correlation was
not confirmed (Table 1, Figure S7). Previously, drugs have been
screened for their effect on polyglutamine aggregate formation using
cellular models. One drug inhibited aggregation and suppressed
neurodegeration [20,21]. Another compound was reported to
promote inclusion formation and prevent the huntingtin-mediated
proteasome dysfunction, which is related to cell toxicity [22,23].
These results and the existence of heterogeneous aggregate species
such as fibrils and oligomers suggest that the decrease of inclusions
might correlate to the change of some specific toxic species of
aggregates depending on the system used.
We further examined the functional relationship among mouse
homologues of the selected candidates (Figure S8). The main gene
group includes nucleotide processing, nucleoporin and signaling.
The signaling genes are related to the autophagy system, which
could degrade polyglutamine aggregates. The role of other major
groups on aggregate formation, such as genes for nucleotide
processing and nucleoporin, is unknown. Since the main
localization of these gene products is nucleus, their function may
be related to the formation of nuclear inclusions. Reduction of the
nucleoporin 160 protein (CG4738) consistently rescued Htt-
induced toxicity and aggregation in our cell line and in vivo.I ti s
feasible, however, that a nucleoporin may act as a docking site for
the accumulation and aggregation of mutant Htt. Further work
remains to elucidate the role of our candidates in the mammalian
system and their mechanism of action.
In summary, we have carried out a thorough screen for
modifiers of mutant human Htt aggregation using new models of
HD established in cultured Drosophila cells and in the fly. Further
investigation of our candidates, particularly those involved in
nucleotide processesing and intracellular transport, including
nuclear transport may uncover, as yet, unexplored pathways
relevant to human Huntington Disease pathogenesis.
Methods
Cloning of Drosophila constructs
We cloned N-terminal Htt exon 1 with 18Q, 62Q or 152Q as
fusions with EGFP and containing a C terminal NLS and MYC
tag into Drosophila expression vectors as described in Supporting
Information.
Establishment of stable, inducible Drosophila cells
expressing Htt exon 1-EGFP
We established stable, single colony-isolated BG2 cell lines
using the DESH system (Invitrogen) as per the manufacturer’s
instructions. Briefly, larval central nervous system-derived
parental cells, BG2-c2 cells [24] were cotransfected with
copper-inducible pRMHa3-NhttEGFP encoding either an 18Q
or a 62Q repeat together with pCoBlast to confer Blasticidin-
resistance. Stably-integrated heterogeneous cells were selected in
the presence of 25 ug/ml Blasticidin. 1–3 cells were seeded into
9 6w e l lp l a t e sa n di s o l a t e dc o l o n i e sw e r ep i c k e da n de x p a n d e d .
Individual clones were checked for expression of the NhttEGFP
transgene by microscopy and Western blot analysis following
induction with CuSO4. Cells were cultured in Schneider’s
Drosophila Medium (Invitrogen) supplemented with 10% heat-
inactivated FBS (Sigma) and 10 mg/ml insulin (Sigma). Medium
was supplemented with 0.5 mM CuSO4 for induction of
NhttEGFP expression. Following initial selection, HD cell lines
were not maintained in Blasticidin.
dsRNA library synthesis
In vitro transcription reactions were set up in 96 well U-bottom
plates (Cellstar) using Ambion T7 megascript kits to simultaneous-
ly synthesize sense and antisense RNA strands in one reaction and
purified as described in Text S1.
ArrayScanH analysis
Fixed, stained cells were analyzed by ArrayScanHV
TI High
Content Screening (HSC) Reader (Cellomics, Pittsburgh, PA,
USA) using Target Activation Bio Application (TABa). TABa
analyzes images acquired by an HSC Reader and provides
measurements of the intracellular fluorescence intensity and
localization on a cell-by-cell basis.
In each well, several thousand cells were counted and quantified
for the number and size of Nhtt(62)EGFP inclusions. Nuclei stained
by Hoechst 33285 provided the autofocus target and scored the
number of quantified cells. Screening consisted of two scans using
Hoechst and FITC (for EGFP) fluorescence. At first, the number of
aggregates was calculated. Fluorescent spots of at least 5 pixels in
size (magnification 406) with an average EGFP intensity of more
than 1500 were labeled as inclusions. Secondly, nuclei were defined
as the objects of interest and their number was determined. EGFP
intensity in each cell was calculated in the perinuclear region within
the distance of 3 pixels from the nucleus and when the average
intensity exceeded 250, the cell was considered as EGFP-positive.
The percentage of the cells with aggregates was calculated.
ArrayScanH data was used to calculate the number of inclusions
per cell (inclusion #/cell) and the inclusion load per cell (inclusion
load/cell), which takes into account the inclusion size (inclusion
number multiplied by inclusion size and divided by the total
number of cells).
Large scale RNAi screening
Detailed methods of our large-scale RNAi screen including
methodology can be found in Text S1.
Fly stocks
NhttEGFP transgenes with either an 18Q or 152Q polygluta-
mine repeat and either with or without a nuclear localization signal
(NLS) were subcloned into pUAST plasmid and injected by
standard methods into w
1118 embryos to establish transgenic flies.
Driver lines used in our analysis were obtained from the
Bloomington stock centre and were recombined with our
transgene(s) for stable expression. Due to CAG repeat instability,
some fly stocks were injected with constructs with repeat lengths
other than 152Q. In such cases, where expressed protein sizes
assessed by Western blotting were inconsistent with a 152Q repeat,
the transgene was amplified by RT-PCR and the CAG repeat
sequenced. UAS-dhdJ1 have been previously described and were
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obtained from the VDRC stock centre [12] in Vienna and the NIG
stock centre in Mishima. UAS-Rheb flies and the GMR-Gal4 and
elav-Gal4 driver lines were obtained from the Bloomington stock
centre. For all autosomal insertion lines and UAS-CG1109 RNAi,
we set up crosses with virgin females carrying our Htt transgenes to
males carrying the candidate transgene. For crosses with UAS-
CG5537 RNAi, virgin females were crossed to HD males.
Prediction of Off-Target Effects
The amplicon sequence for each dsRNA in the Open
Biosystems library was automatically retrieved from the FLIGHT
database and entered into the Drosophila Resource Screening
Center (DRSC) OTE search tool to predict the number of
potential Off-Target Effects with a 19 nt match.
De novo design of amplicons for RNAi
The transcript sequences for the final candidates were retrieved
from FlyBase and the region targeted by the Open Biosystems
dsRNA was manually highlighted. Transcript sequence not
targeted by the library was used to design T7-tagged oligos for
amplication of de novo RNAi probes using the E-RNAi tool
(Heidlberg, Germany). Where possible, probes were selected to
target all possible transcripts of a given gene and had no predicted
21 nt OTEs.
Synthesis of de novo RNAi probes
To prepare the template for PCR amplification of the target
regions for in vitro transcription (IVT), total RNA was prepared
from 200 liquid N2 freeze-dried whole w
1118 flies using TRIzolH
reagent (Invitrogen). Oligo d(T)-primed cDNA was synthesized
from 2 mg total RNA, using First Strand cDNA synthesis kit
according to the Manufacturer’s directions (Novagen). 3 ml were
used in a standard PCR reaction using KODPlus DNA
polymerase (TOYOBO, Japan) and using the primer pairs
designed as described above and synthesized by Operon. PCR
products were purified using the Vacuum ManifoldH system
(Millipore) and a sample was checked by agarose gel electropor-
esis. Purified PCR products containing T7 promoters at each end
were used as templates for in vitro transcription using the
Megascript T7 kit (Ambion) according to the manufacturer’s
directions. dsRNA is automatically made as each strand is
synthesized in a single reaction. dsRNAs were purified using the
Millipore Vacuum Manifold system and the concentration
calculated by spectrophotometry. In cases where multiple bands
were observed in the PCR product, the band of the correct size
was excised and purified using the WizardH Gel and PCR Clean-
Up kit (Promega) before being used as a template for IVT.
Tertiary Screening using de novo dsRNAs
Based on calculations of Clemens et al, 2000 we brought each
dsRNA to 860 nM stock and aliquoted the appropriate amounts
for 43 nM and 108 nM treatments into 96 well plates. Cells were
treated with each de novo dsRNA probe in duplicate on separate
experimental days and in different well positions. Each plate was
arrayed with controls against NewLacZ, diap1 and dhdJ1 (hsp40).
Scores were normalized by dividing the inclusions/cell value by
the NewLacZ control value. Averaged, normalized scores for #
inclusions/cell and inclusion load/cell were calculated.
Western Blot analysis
BG2-Nhtt(62Q)EGFP cells were treated with 43 nM dsRNAs
for 48 hours in 12 well plates and the culture medium was
replaced with induction medium containing 0.5 mM CuSO4 for
16 hours. Cells were washed in PBS and then harvested in 1%
SDS/PBS supplemented with CompleteH Protease Inhibitor
Cocktail (Roche), and divided into two for WB analysis and
prepareation of total RNA. Cells for WB analysis were lysed by
sonication, gently centrifuged and the protein concentration
measured by BCA assay. 3 mg of whole cell lysates were boiled
in LDS sample buffer/DTT and electrophoresed at 200 V
through a 4–12% NuPAGE gel (Invitrogen) in MOPS buffer.
Proteins were transferred wet onto PVDF (Millipore) membrane,
blocked in 10% skim milk and blotted with EM48 MAB5374
Huntingtin primary antibody (Millipore) and Mouse IgG Perox-
idase (GE healthcare) secondary antibody before detection using
ECL. Images were captured using LAS-1000 (Fujifilm). Blots were
stripped and re-probed with E7 b-tubulin antibody (Hybridoma
Bank) and Mouse IgG Peroxidase (GE). The presence of
aggregates in whole cell lysates makes quantification difficult,
resulting in some apparent loading differences between samples.
Imaging of adult fly eyes
Fly progeny were collected every 24 hours over a 5 day period
and aged for 3 weeks (21–22 days). Flies were randomly selected,
anesthetized with CO2 and decapitated. Fly heads were aligned on
a slide for imaging the left eye and viewed using an Olympus
SZX16 dissecting microscope and an external light source
(Kenko). Images were captured using a NIKON digital sight
DS-L1 camera.
In vivo scoring of aggregation
For quantification of inclusions in the adult brain, brains from
male flies aged for 4 weeks (28–29 days) were dissected in PBS and
immediately fixed in 4% PFA for 30–60 minutes. Brains were
fixed in paraformaldehyde and stained with elav antibody
(Developmental Hybridoma Bank, Iowa, USA). Using a 10X
objective lens, 5 mm z sections were imaged using a SP2nLeica
Confocal and images were converted to greyscale JPEG images
using Photoshop and then opened in ImageJ [25] for quantifica-
tion of aggregation. In some cases, highly fluorescent areas clearly
not inclusions, were removed to avoid artificial inclusion counts.
The number and size of Htt(93Q)EGFP inclusions were quantified
using ImageJ software on greyscale brain images captured by
confocal microscopy using the green channel only. Threshold
settings were set to a minimum of 100 and the default maximum
(255). Using the ‘Analyze Particles’ option, the inclusion number
and average inclusion size were calculated. We were unable to
confirm expression levels of our candidates in adult brain by
RTPCR, probably because contribution of non-RNAi targeted
cell types contributing to the total RNA prepared could mask any
reduction in elav-positive cells. We were able to detect the
overexpression of dhdJ1 and Rheb in the eye model, suggesting
that these transgenes are effectively overexpressing these genes
(data not shown).
Supporting Information
Text S1 Supporting Materials and Methods
Found at: doi:10.1371/journal.pone.0007275.s001 (0.03 MB
DOC)
Figure S1 RNAi screening validation and overview. The
efficacy of RNAi treatment in a Drosophila cell culture model of
HD was tested using dsRNA against GFP. Cells expressing BG2-
Nhtt(18Q)EGFP cells treated with 37 nM GFP dsRNA for
48 hours and visualized by fluorescence microscopy show ablation
of GFP (A). BG2-Nhtt(62Q)EGFP cells were treated with GFP
Modifiers of Aggregation
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Nhtt(62Q)EGFP by GFP dsRNA reduced the number of EGFP-
positive cells (B) and the number of EGFP-positive intracellular
inclusions (C) detected by ArrayScanH. Screening in 96 well plate
format was validated using a screen plate arrayed with random
dsRNAs including dsRNA against diap1. Loss of diap1 results in
widespread apoptosis as shown by the reduced viability in cells
treated with diap1 dsRNA (D). An overview of our approach to
screening for modifiers of mutant Htt aggregation, including
several rounds of screening in vitro, followed by validation in vivo,
is shown (E).
Found at: doi:10.1371/journal.pone.0007275.s002 (2.33 MB TIF)
Figure S2 OTE pruning following primary screening. Top pie
charts show the functional categorization of all candidates
following primary screening in BG2-Nhtt(62)EGFP cells. These
candidates were pruned to eliminated dsRNAs with more than 10
predicted OTEs. The Specific Transcription category, including
many transcription factors (TFs) was the most drastically reduced
following OTE pruning, consistent with the fact that many
TFs have repetitive trinucleotide repeats that are sensitive to
off-targeting.
Found at: doi:10.1371/journal.pone.0007275.s003 (1.81 MB TIF)
Figure S3 Off-target effects reduce cell viability and contribute
to false positive candidates. The mean cell viability values for
candidates following primary screening were plotted against the
number of predicted 19 nt OTEs, demonstrating a significant
negative correlation between cell viability and the number of
potential OTEs (A). dsRNAs with multiple predicted OTEs are
over-represented amongst our candidates following the primary
screen. 54% of the dsRNA target sequences in the Open
Biosystems library have no predicted 19 nt OTEs, with only
5.7% having more than 10 predicted OTEs (B). In contrast, 30%
of our candidates lacked any predicted OTEs, with 44% having
greater than 10 potential off-targets (C). The presence of off-target
sequences causes inconsistencies in assay results. The percentage of
candidates that modified Nhtt(62Q)EGFP consistently from the
primary screen, using library dsRNAs, and the tertiary screen,
using de novo designed dsRNAs are shown in yellow. The
percentage of candidates producing an opposite effect is shown in
green, while pink shows the percentage of candidates that gave
inconsistent results within the tertiary screen duplicates using de
novo dsRNAs with no 21 nt OTEs. The majority of candidates
with no more than 1 OTE consistently modified mutant Htt
aggregation in vitro. Increasing OTEs increased the likelihood of
inconsistent results (D).
Found at: doi:10.1371/journal.pone.0007275.s004 (2.19 MB TIF)
Figure S4 de novo RNAi probes. Target sequences were
amplified with primers harboring the T7 promoter sequence.
PCR products were purified using the Millipore Vacuum manifold
system and checked for size and product specificity by agarose gel
electrophoresis (top panel). In cases where more than one product
was amplified, the product of the correct size was excised from the
gel and purified. These products were then checked again by
agarose gel electrophoresis (top right panel). To confirm the
integrity of dsRNA synthesized in vitro from the PCR product
templates, we ran 1 mg dsRNA on a denaturing formaldehyde gel
(lower panel). Predominant bands are consistent with the predicted
size for denatured RNA. We suspect the minor slower-migrating
bands are non-denatured dsRNAs (A). By using RTPCR in BG2-
Nhtt(62Q)EGFP cells treated with candidate groups 1–3 dsRNAs,
we confirmed that in each case, the target gene was reduced upon
dsRNA treatment. All results were from the same experiment
except ATPsyn-b (boxed), which was from a different experiment
(B).
Found at: doi:10.1371/journal.pone.0007275.s005 (1.59 MB TIF)
Figure S5 Confocal microscopy of RNAi-treated cells. BG2-
Nhtt(62Q)EGFP cells treated with candidate groups 1–3 aggrega-
tion-suppressing (A) and aggregation-enhancing (B) dsRNAs. To
demonstrate the increase in diffuse-expressing cells among
aggregation-suppressors, the EGFP gain was increased to 400
compared with a gain setting of 300 for imaging the aggregation-
enhancing dsRNAs.
Found at: doi:10.1371/journal.pone.0007275.s006 (6.00 MB TIF)
Figure S6 Confocal projection images of 3rd instar larval eye
imaginal discs. Wandering 3rd instar larval eye discs were
dissected in PBS, fixed in 4% PFA, stained with Hoechst and
mounted onto a microscope slide in 80% glycerol for imaging
using a Leica SP2 confocal microscope. Flies expressing
Nhtt(18Q)EGFP together with Nhtt(18Q)EGFPNLS show local-
ization of the protein in the nucleus (white arrow heads) and in the
cytoplasm (white arrows) (left panels). Flies expressing mutant
Nhtt(152Q)EGFP together with Nhtt(48Q)EGFPNLS show the
presence of EGFP-positive nuclear (arrow heads) and cytoplasmic
(white arrows) inclusions in larval eye imaginal discs (right panels).
Images represent projection stacks of 5 mm z sections.
Found at: doi:10.1371/journal.pone.0007275.s007 (2.47 MB TIF)
Figure S7 Correlation between inclusion number/load and cell
viability. Based on the data shown in Table 1, the values of %
viability were plotted against those of fold change in the number of
inclusions or inclusion load for all candidate genes. A weak positive
correlation was observed between cell viability and both number
of inclusions (r=0.436, P=0.048) and inclusion load (r=0.444,
P=0.044).
Found at: doi:10.1371/journal.pone.0007275.s008 (2.46 MB TIF)
Figure S8 Functional grouping of mammalian orthologues of
the candidate genes. The mammalian orthologues of the candidate
genes (Table 1) identified by RNAi screening were categorized
according to their known or predicted functions manually
retrieved from the public databases such as PUBMED, Entrez
Gene, and HomoloGene. Mammalian orthologues of enhancers
and suppressors dsRNAs in the fly are shown by red- and blue-
colored circles, respectively.
Found at: doi:10.1371/journal.pone.0007275.s009 (3.79 MB TIF)
Data S1 Excel file: Full List Functional Assign Worksheet: 2SDs
full list All candidates with z scores of greater than 2 or less than
22 are shown in this worksheet, with data for Gene Ontology
categorization and manual functional grouping. The effect on
mutant Htt aggregation is abbreviated as either enhancing
aggregation (en) or suppressing aggregation (su). The predicted
number of 19 nt OTEs and the mean % viability values are
shown. Given the continual updating of public databases, current
information may differ from information obtained at the time this
spreadsheet was made. Worksheet: en 1.5 to 2 Weaker enhancer
dsRNAs with z scores between 1.5 and 2 are shown with all the
data entries as above.
Found at: doi:10.1371/journal.pone.0007275.s010 (0.51 MB
XLS)
Acknowledgments
We thank Ritsuko Kazama for synthesis of the dsRNA from library
templates and to Dr. Peter Bauer for assistance with ArrayScanH operation.
We are grateful to Prof. Masayuki Miura and Assoc. Prof. Erina Kuranaga
for helpful discussions regarding the project design and in vivo methodology.
Modifiers of Aggregation
PLoS ONE | www.plosone.org 11 September 2009 | Volume 4 | Issue 9 | e7275We thank the Bloomington, VDRC and NIG stock centers for provision of
flies. UAS-dhdJ1 flies were a kind gift from Prof. Kazemi-Esfarjani.
Author Contributions
Conceived and designed the experiments: JD NN. Performed the
experiments: JD KW. Analyzed the data: JD YK. Contributed reagents/
materials/analysis tools: JD KW AWM. Wrote the paper: JD NN.
Discussions and project supervision: NN. The design and implementation
of the experiments including establishment of cell culture and in vivo
models: JD. Carrying out the RNAi high-throughput screen, data analysis,
cell treatments, microscopy, de novo probe design and all in vivo
experiments: JD. Synthesis and purification of dsRNAs, Western blot
analysis, and RTPCR: KW. Analysis the functional roles of selected
candidates and other data: YK. Support of Fly maintenance materials and
facilities: AWM.
References
1. Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington’s
disease. Eur J Neurosci 27: 2803–2820.
2. Celotto AM, Palladino MJ (2005) Drosophila: a ‘‘model’’ model system to study
neurodegeneration. Mol Interv 5: 292–303.
3. Sang TK, Jackson GR (2005) Drosophila models of neurodegenerative disease.
NeuroRx 2: 438–446.
4. Bilen J, Bonini NM (2005) Drosophila as a model for human neurodegenerative
disease. Annu Rev Genet 39: 153–171.
5. Marsh JL, Thompson LM (2004) Can flies help humans treat neurodegenerative
diseases? Bioessays 26: 485–496.
6. Ramadan N, Flockhart I, Booker M, Perrimon N, Mathey-Prevot B (2007)
Design and implementation of high-throughput RNAi screens in cultured
Drosophila cells. Nat Protoc 2: 2245–2264.
7. Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, et al. (2000)
Use of double-stranded RNA interference in Drosophila cell lines to dissect
signal transduction pathways. Proc Natl Acad Sci U S A 97: 6499–6503.
8. Kulkarni MM, Booker M, Silver SJ, Friedman A, Hong P, et al. (2006) Evidence
of off-target effects associated with long dsRNAs in Drosophila melanogaster
cell-based assays. Nat Methods 3: 833–838.
9. Ma Y, Creanga A, Lum L, Beachy PA (2006) Prevalence of off-target effects in
Drosophila RNA interference screens. Nature 443: 359–363.
10. Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, et al. (2007) Huntingtin has a
membrane association signal that can modulate huntingtin aggregation, nuclear
entry and toxicity. Hum Mol Genet 16: 2600–2615.
11. Arziman Z, Horn T, Boutros M (2005) E-RNAi: a web application to design
optimized RNAi constructs. Nucleic Acids Res 33: W582–588.
12. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, et al. (2007) A genome-
wide transgenic RNAi library for conditional gene inactivation in Drosophila.
Nature 448: 151–156.
13. Cornett J, Cao F, Wang CE, Ross CA, Bates GP, et al. (2005) Polyglutamine
expansion of huntingtin impairs its nuclear export. Nat Genet 37: 198–204.
14. Murata T, Suzuki E, Ito S, Sawatsubashi S, Zhao Y, et al. (2008) RNA-binding
protein hoip accelerates polyQ-induced neurodegeneration in Drosophila. Biosci
Biotechnol Biochem 72: 2255–2261.
15. Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, et al. (2008) RNA-
binding protein TLS is a major nuclear aggregate-interacting protein in
huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem
283: 6489–6500.
16. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. (2004) Inhibition of
mTOR induces autophagy and reduces toxicity of polyglutamine expansions in
fly and mouse models of Huntington disease. Nat Genet 36: 585–595.
17. Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated
clearance of huntingtin aggregates triggered by the insulin-signaling pathway.
J Cell Biol 172: 719–731.
18. Kazemi-Esfarjani P, Benzer S (2000) Genetic suppression of polyglutamine
toxicity in Drosophila. Science 287: 1837–1840.
19. Bai J, Binari R, Ni JQ, Vijayakanthan M, Li HS, et al. (2008) RNA interference
screening in Drosophila primary cells for genes involved in muscle assembly and
maintenance. Development 135: 1439–1449.
20. Zhang X, Smith DL, Meriin AB, Engemann S, Russel DE, et al. (2005) A potent
small molecule inhibits polyglutamine aggregation in Huntington’s disease
neurons and suppresses neurodegeneration in vivo. Proc Natl Acad Sci U S A
102: 892–897.
21. Desai UA, Pallos J, Ma AA, Stockwell BR, Thompson LM, et al. (2006)
Biologically active molecules that reduce polyglutamine aggregation and toxicity.
Hum Mol Genet 15: 2114–2124.
22. Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, et al. (2006)
Pharmacological promotion of inclusion formation: a therapeutic approach for
Huntington’s and Parkinson’s diseases. Proc Natl Acad Sci U S A 103:
4246–4251.
23. Jana NR, Zemskov EA, Wang G, Nukina N (2001) Altered proteasomal function
due to the expression of polyglutamine-expanded truncated N-terminal
huntingtin induces apoptosis by caspase activation through mitochondrial
cytochrome c release. Hum Mol Genet 10: 1049–1059.
24. Ui-Tei K, Nagano M, Sato S, Miyata Y (2000) Calmodulin-dependent and -
independent apoptosis in cell of a Drosophila neuronal cell line. Apoptosis 5:
133–140.
25. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with imageJ.
Biophotonics Int 11: 36–42.
Modifiers of Aggregation
PLoS ONE | www.plosone.org 12 September 2009 | Volume 4 | Issue 9 | e7275